Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Temporarily pausedNCT05198479
What this trial is testing

Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in

Who this might be right for
Metastatic Nasopharyngeal Cancer
National Cancer Centre, Singapore 25
Testing effectiveness (Phase 2)Looking for participantsNCT07253896
What this trial is testing

Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab

Who this might be right for
Safety
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Testing effectiveness (Phase 2)Study completedNCT00045188
What this trial is testing

Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 35
Not applicableUnknownNCT06447727
What this trial is testing

Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM

Who this might be right for
Colorectal Cancer Metastatic
Zhongda Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00376805
What this trial is testing

Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 6
Large-scale testing (Phase 3)Active Not RecruitingNCT05450692
What this trial is testing

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

Who this might be right for
Advanced or Metastatic Non-Small Cell Lung Cancer
AstraZeneca 594
Testing effectiveness (Phase 2)UnknownNCT00081536
What this trial is testing

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Who this might be right for
Colorectal Neoplasms
Aronex Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT04561336
What this trial is testing

Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerRAS Wild Type
University of Campania Luigi Vanvitelli 77
Early research (Phase 1)Study completedNCT02180698
What this trial is testing

TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Stage III Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma
Fred Hutchinson Cancer Center 16
Not applicableLooking for participantsNCT06768463
What this trial is testing

Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer

Who this might be right for
Metastatic Gastric CancerGastric CancerSystemic Therapy+1 more
University Medical Center Ho Chi Minh City (UMC) 250
Early research (Phase 1)Looking for participantsNCT07108114
What this trial is testing

SLV-324 Treatment of Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Solve Therapeutics 70
Testing effectiveness (Phase 2)Study completedNCT00503906
What this trial is testing

Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of Miami 30
Testing effectiveness (Phase 2)Study completedNCT01149304
What this trial is testing

Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity

Who this might be right for
Colorectal CancerLiver MetastasesIrradiation Damage+1 more
University of Magdeburg 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT07802704
What this trial is testing

Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 684
Testing effectiveness (Phase 2)Study completedNCT02278133
What this trial is testing

Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations

Who this might be right for
Metastatic Colorectal Cancer
Array BioPharma 20
Testing effectiveness (Phase 2)Ended earlyNCT01857752
What this trial is testing

Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala

Who this might be right for
Retinoblastoma
Stanford University 3
Testing effectiveness (Phase 2)WithdrawnNCT03592407
What this trial is testing

Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal AdenocarcinomaGastroesophageal Junction Adenocarcinoma
City of Hope Medical Center
Large-scale testing (Phase 3)Study completedNCT02613507
What this trial is testing

Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 504
Not applicableUnknownNCT03947736
What this trial is testing

Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR

Who this might be right for
Recurrent or Metastatic Breast Cancer
Chinese Academy of Medical Sciences 200
Early research (Phase 1)Study completedNCT03256344
What this trial is testing

Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases

Who this might be right for
Metastatic Triple Negative Breast CancerMetastatic Colorectal Cancer
Amgen 36
Next Page